mp:Vdraft Sandbox: verschil tussen versies

Uit informatiestandaarden
Naar navigatie springen Naar zoeken springen
← Oudere bewerking
Wetering (overleg | bijdragen)
Write
3.043 bewerkingen
Geen bewerkingssamenvatting
Wetering (overleg | bijdragen)
Write
3.043 bewerkingen
Geen bewerkingssamenvatting
 
(199 tussenliggende versies door 2 gebruikers niet weergegeven)
Regel 1: Regel 1:
{{anchor|tabel1}}
{| class="wikitable" "cellpadding="10"
|+Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
|-
! style="text-align:left;"|Situatie
! style="text-align:left;"|EVS
! style="text-align:left;"|AIS
! style="text-align:left;"|ETDR
|-
! style="text-align:left;"|Migreren van actuele en recent gestopte medicatie
| style="background-color: white;vertical-align:top;"|Specifieke MBH-id||Generieke MBH-id
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
|-
! style="text-align:left;"|Migreren van historische medicatie
| style="background-color: white;vertical-align:top;"|Generieke MBH-id||Generieke MBH-id
| style="background-color: white;vertical-align:top;"|Generieke MBH-id
|-
! style="text-align:left;"|Starten van nieuwe MBH
| style="background-color: white;vertical-align:top;"|Specieke MBH-id||Generieke MBH-id<ref>AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf [[#Bijzondere situaties|Bijzondere situaties]]).</ref>
| style="background-color: white;vertical-align:top;"|Generieke MBH-id


__NUMBEREDHEADINGS__
|-
{{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}}
 
=Addenda voor inhoudelijke gegevens=
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem ==
 
=== Scenarioset 0===
<section begin=overview-MGB-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| || Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria<br/>(Antwoord: bericht met 6 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| || Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.3 optioneel|| || Medicatieafspraken met een filter op product code (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| || Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| || Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| || Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| || Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
|}
<section end=overview-MGB-0 />
=== Scenarioset 1===
<section begin=overview-MGB-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| || Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| || Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC
|}
<section end=overview-MGB-1 />
=== Scenarioset 2===
<section begin=overview-MGB-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie'  zichtbaar is|| Aanvullende informatie|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| || Toedieningsweg|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK
|}
<section end=overview-MGB-2 />
=== Scenarioset 3===
<section begin=overview-MGB-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| || Stop-medicatieafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br/>MBH_920_toelichting_MA_techstaken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br/>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.4 optioneel|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Onderbreken medicatieafspraak<br/>LET OP: onderbreking medicatieafspraak van scenario 2.4|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
|}
<section end=overview-MGB-3 />
=== Scenarioset 4===
<section begin=overview-MGB-4 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|4.1|| Maak screenshot(s) waarin zichtbaar is dat er een lengte en gewicht ingevoerd kunnen worden|| Medicatieafspraak met lengte en gewicht|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN
|}
<section end=overview-MGB-4 />
=== Scenarioset 6===
<section begin=overview-MGB-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1 optioneel|| || Variabele frequentie|| MBH_920_variabelefrequentie-MSZ|| MBH_920_variabelefrequentie_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.2 optioneel|| || Interval|| MBH_920_interval-MSZ|| MBH_920_interval_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.3 optioneel|| || Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid-MSZ|| MBH_920_variabelehoeveelheid_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.4 optioneel|| || Zonder keerdosis|| MBH_920_zonderkeerdosis-MSZ|| MBH_920_zonderkeerdosis_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.5 optioneel|| || Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis-MSZ|| MBH_920_bijzonderekeerdosis_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.6 optioneel|| || Variabele hoeveelheid (2)|| MBH_920_variabelehoeveelheid2-MSZ|| MBH_920_variabelehoeveelheid2_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.7*|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen|| MBH_920_tijdstippen-MSZ|| MBH_920_tijdstippen_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.8 optioneel|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_920_weekdagen-MSZ|| MBH_920_weekdagen_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.9*|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_920_dagdeel-MSZ|| MBH_920_dagdeel_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.10 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_920_cyclischschema-MSZ|| MBH_920_cyclischschema_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.11 optioneel|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_920_afbouwschema-MSZ|| MBH_920_afbouwschema_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.12 optioneel|| || Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum-MSZ|| MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.13 optioneel|| || Toedieningssnelheid|| MBH_920_toedieningssnelheid-MSZ|| MBH_920_toedieningssnelheid_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.14 optioneel|| || Toedieningsduur|| MBH_920_toedieningsduur-MSZ|| MBH_920_toedieningsduur_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| MBH_920_zonodig-MSZ|| MBH_920_zonodig_MA-MSZ
|}
<section end=overview-MGB-6 />
=== Scenarioset 7===
<section begin=overview-MGB-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_920_magistraalalleingredienten-TST|| MBH_920_magistraalalleingredienten_MA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.2 optioneel|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_920_magistraalactieveingredient-TST|| MBH_920_magistraalactieveingredient_MA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.3 optioneel|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr-TST|| MBH_920_magistraal90miljoennr_MA-TST
|}
<section end=overview-MGB-7 />
=== Scenarioset 8===
<section begin=overview-MGB-8 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|8.1|| Maak screenshot waarop zichtbaar is dat andermans MA in het systeem zit|| Andermans medicatieafspraak (met kopie indicator)|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
|}
<section end=overview-MGB-8 />
=== Scenarioset 8i===
<section begin=overview-MGB-8i />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|8i.01|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.1|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.02|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.2|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.03|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.3|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.04|| || Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.4|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP
|}
<section end=overview-MGB-8i />
=== Scenarioset 10===
<section begin=overview-MGB-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1 optioneel|| || HPK geneesmiddel|| MBH_920_HPKvoorschrijven-KST|| MBH_920_HPKvoorschrijven_MA-KST
|-style="vertical-align:top;|style="background-color: white;"
|10.2 optioneel|| || ZI-nr geneesmiddel|| MBH_920_ZINRvoorschrijven-KST|| MBH_920_ZINRvoorschrijven_MA-KST
|}
<section end=overview-MGB-10 />
== Overzicht van scenario's voor ontvangend/raadplegend systeem ==
 
=== Scenarioset 0===
<section begin=overview-MGR-0 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving
|-style="vertical-align:top;|style="background-color: white;"
|0.1|| Alle medicatieafspraken van de patiënt, zonder aanvullende filter criteria<br/>(Antwoord: bericht met 6 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.2|| Specifieke medicatieafspraak met identificaties als filter (in kwalificatiesimulator het id van "MBH_920_QA1_MA" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.3|| Medicatieafspraken met een filter op product code (PRK 3956)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.4|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum (alles vanaf T-21)<br/>(Antwoord: bericht met 4 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.5|| Medicatieafspraken met een filter op gebruiksperiode – einddatum (alles voor T-22)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.6|| Medicatieafspraken met een filter op gebruiksperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7)<br/>(Antwoord: bericht met 3 medicatieafspraken)
|-style="vertical-align:top;|style="background-color: white;"
|0.7|| Medicatieafspraken met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_920_QA1" invoeren)<br/>(Antwoord: bericht met 1 medicatieafspraak)
|-style="vertical-align:top;|style="background-color: white;"
|0.8|| Een antwoord zonder medicatieafspraken (filter op gebruiksperiode – einddatum (alles voor T-110))<br/>(Antwoord: bericht zonder medicatieafspraken)
|}
<section end=overview-MGR-0 />
=== Scenarioset 1===
<section begin=overview-MGR-1 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|1.1|| Medicatieafspraak gebruiksperiode ingangsdatum en einddatum|| MBH_920_start_eind-BSC|| MBH_920_start_eind_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2a|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (weken)|| MBH_920_start_duur-BSC|| MBH_920_start_duur_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.2b|| Medicatieafspraak gebruiksperiode ingangsdatum en duur (dagen)|| MBH_920_start_duur2-BSC|| MBH_920_start_duur2_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.3|| Medicatieafspraak gebruiksperiode ingangsdatum (chronische medicatie)|| MBH_920_chronisch-BSC|| MBH_920_chronisch_MA-BSC
|-style="vertical-align:top;|style="background-color: white;"
|1.4|| Medicatieafspraak met eenheid 'dosis/stuks'|| MBH_920_dosis_stuks-BSC|| MBH_920_dosis_stuks_MA-BSC
|}
<section end=overview-MGR-1 />
=== Scenarioset 2===
<section begin=overview-MGR-2 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|2.1|| Aanvullende instructie|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.2|| Toelichting|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.3|| Reden van voorschrijven|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.4|| Aanvullende informatie|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA-VNK
|-style="vertical-align:top;|style="background-color: white;"
|2.5|| Toedieningsweg|| MBH_920_Toedieningsweg-VNK|| MBH_920_Toedieningsweg_MA-VNK
|}
<section end=overview-MGR-2 />
=== Scenarioset 3===
<section begin=overview-MGR-3 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|3.1|| Stop-medicatieafspraak, met reden staken<br/>LET OP: stop medicatieafspraak van scenario 2.1|| MBH_920_aanvullendeinstructie-VNK|| MBH_920_aanvullendeinstructie_MA_staken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.2|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.2|| MBH_920_toelichting-VNK|| MBH_920_toelichting_MA_wijzigingmetVV-VNK<br/>MBH_920_toelichting_MA_techstaken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.3|| Wijziging medicatieafspraak, met reden wijziging (stop-ma + nieuwe ma)<br/>LET OP: wijziging medicatieafspraak van scenario 2.3|| MBH_920_redenvanvoorschrijven-VNK|| MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK<br/>MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
|-style="vertical-align:top;|style="background-color: white;"
|3.4|| Onderbreken medicatieafspraak<br/>LET OP: onderbreking medicatieafspraak van scenario 2.4|| MBH_920_aanvullendeinformatiewensen-VNK|| MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
|}
<section end=overview-MGR-3 />
=== Scenarioset 4===
<section begin=overview-MGR-4 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|4.1|| Medicatieafspraak met lengte en gewicht|| MBH_920_Lengte_Gewicht-MLN|| MBH_920_Lengte_Gewicht_MA_1-MLN
|}
<section end=overview-MGR-4 />
=== Scenarioset 6===
<section begin=overview-MGR-6 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|6.1|| Variabele frequentie|| MBH_920_variabelefrequentie-MSZ|| MBH_920_variabelefrequentie_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.2|| Interval|| MBH_920_interval-MSZ|| MBH_920_interval_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.3|| Variabele hoeveelheid (1)|| MBH_920_variabelehoeveelheid-MSZ|| MBH_920_variabelehoeveelheid_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.4|| Zonder keerdosis|| MBH_920_zonderkeerdosis-MSZ|| MBH_920_zonderkeerdosis_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.5|| Bijzondere keerdosis|| MBH_920_bijzonderekeerdosis-MSZ|| MBH_920_bijzonderekeerdosis_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.6|| Variabele hoeveelheid (2)|| MBH_920_variabelehoeveelheid2-MSZ|| MBH_920_variabelehoeveelheid2_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.7|| Tijdstippen|| MBH_920_tijdstippen-MSZ|| MBH_920_tijdstippen_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.8|| Weekdagen|| MBH_920_weekdagen-MSZ|| MBH_920_weekdagen_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.9|| Dagdeel|| MBH_920_dagdeel-MSZ|| MBH_920_dagdeel_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.10|| Cyclisch schema|| MBH_920_cyclischschema-MSZ|| MBH_920_cyclischschema_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.11|| Afbouw schema en doseerduur|| MBH_920_afbouwschema-MSZ|| MBH_920_afbouwschema_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.12|| Variabele hoeveelheid en maximum|| MBH_920_variabelehoeveelheidenmaximum-MSZ|| MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.13|| Toedieningssnelheid|| MBH_920_toedieningssnelheid-MSZ|| MBH_920_toedieningssnelheid_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.14|| Toedieningsduur|| MBH_920_toedieningsduur-MSZ|| MBH_920_toedieningsduur_MA-MSZ
|-style="vertical-align:top;|style="background-color: white;"
|6.15|| Zo nodig|| MBH_920_zonodig-MSZ|| MBH_920_zonodig_MA-MSZ
|}
<section end=overview-MGR-6 />
=== Scenarioset 7===
<section begin=overview-MGR-7 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|7.1|| Alle ingrediënten|| MBH_920_magistraalalleingredienten-TST|| MBH_920_magistraalalleingredienten_MA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.2|| Actief ingrediënt|| MBH_920_magistraalactieveingredient-TST|| MBH_920_magistraalactieveingredient_MA-TST
|-style="vertical-align:top;|style="background-color: white;"
|7.3|| 90 miljoen nummer|| MBH_920_magistraal90miljoennr-TST|| MBH_920_magistraal90miljoennr_MA-TST
|}
<section end=overview-MGR-7 />
=== Scenarioset 8===
<section begin=overview-MGR-8 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|8.1|| Andermans medicatieafspraak (met kopie indicator)|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
|}
<section end=overview-MGR-8 />
=== Scenarioset 8i===
<section begin=overview-MGR-8i />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|8i.01|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.1|| MBH_920_VVandermansMA-ZTP|| MBH_920_VVandermansMA_MA-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.02|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.2|| MBH_920_stakenandermansMA-ZTP|| MBH_920_stakenandermansMA_MA1-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.03|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.3|| MBH_920_onderbrekenandermansMA-ZTP|| MBH_920_onderbrekenandermansMA_MA1-ZTP
|-style="vertical-align:top;|style="background-color: white;"
|8i.04|| Andermans medicatieafspraak  ontvangen ter voorbereiding MP-VOS scenario 8.4|| MBH_920_wijzigenandermansMA-ZTP|| MBH_920_wijzigenandermansMA_MA1-ZTP
|}
<section end=overview-MGR-8i />
=== Scenarioset 10===
<section begin=overview-MGR-10 />
{| class="wikitable"
|-style="background-color: #1F497D;; color: white; text-align:left;"
| Scenario|| Beschrijving|| MBH id|| MA id
|-style="vertical-align:top;|style="background-color: white;"
|10.1|| HPK geneesmiddel|| MBH_920_HPKvoorschrijven-KST|| MBH_920_HPKvoorschrijven_MA-KST
|-style="vertical-align:top;|style="background-color: white;"
|10.2|| ZI-nr geneesmiddel|| MBH_920_ZINRvoorschrijven-KST|| MBH_920_ZINRvoorschrijven_MA-KST
|}
<section end=overview-MGR-10 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-1 />
==== Scenario 0.1 - MBH_920_QA1-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA1-JNK
|}
==== Scenario 0.1 - MBH_920_QA2-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA2_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA2_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e204
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-100D{00:00:00}> t/m T-72D{23:59:59}, 1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA2-JNK
|}
==== Scenario 0.1 - MBH_920_QA3-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e399
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA3-JNK
|}
==== Scenario 0.1 - MBH_920_QA4-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e583
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA4-JNK
|}
==== Scenario 0.1 - MBH_920_QA5-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA5_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA5_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e764
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>, gedurende 7 dagen, 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA5-JNK
|}
==== Scenario 0.1 - MBH_920_QA6-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA6_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA6_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e945
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-5D{00:00:00}> t/m <T+1D{23:59:59}>, 2 maal per dag 2 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA6-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-1 /><section end=mg-mgr-mg-MA-Scenarioset0-0-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-2 />
==== Scenario 0.2 - MBH_920_QA1-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA1-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-2 /><section end=mg-mgr-mg-MA-Scenarioset0-0-2 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
==== Scenario 0.3 - MBH_920_QA4-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e583
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA4-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset0-0-3optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-4 />
==== Scenario 0.4 - MBH_920_QA1-JNK====
 
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
 
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA1-JNK
|}
|}
==== Scenario 0.4 - MBH_920_QA3-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e399
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA3-JNK
|}
==== Scenario 0.4 - MBH_920_QA4-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e583
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA4-JNK
|}
==== Scenario 0.4 - MBH_920_QA6-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA6_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA6_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e945
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-5D{00:00:00}> t/m <T+1D{23:59:59}>, 2 maal per dag 2 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA6-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-4 /><section end=mg-mgr-mg-MA-Scenarioset0-0-4 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-5 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-5 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-5 />
==== Scenario 0.5 - MBH_920_QA2-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA2_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA2_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e204
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-100D{00:00:00}> t/m T-72D{23:59:59}, 1 maal per dag 10 ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA2-JNK
|}
==== Scenario 0.5 - MBH_920_QA3-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e399
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA3-JNK
|}
==== Scenario 0.5 - MBH_920_QA5-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA5_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA5_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e764
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>, gedurende 7 dagen, 1 maal per dag 1 stuk
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA5-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-5 /><section end=mg-mgr-mg-MA-Scenarioset0-0-5 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-6 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-6 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-6 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-6 />
==== Scenario 0.6 - MBH_920_QA1-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA1-JNK
|}
==== Scenario 0.6 - MBH_920_QA3-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA3_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA3_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e399
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-50D{00:00:00}>t/m <T-11D{23:59:59}>, 2 maal per dag 50 ml, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA3-JNK
|}
==== Scenario 0.6 - MBH_920_QA4-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA4_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA4_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e583
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-10D{00:00:00}> t/m <T+19D{23:59:59}>, 1 keer per dag 3 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA4-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-6 /><section end=mg-mgr-mg-MA-Scenarioset0-0-6 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-7 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-7 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-7 />
==== Scenario 0.7 - MBH_920_QA1-JNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_QA1_MA-JNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_QA1_MA-JNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-20D{00:00:00}>t/m <T+9D{23:59:59}>, 1 maal per dag 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_QA1-JNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-7 /><section end=mg-mgr-mg-MA-Scenarioset0-0-7 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 0 (filterqueries)==
<section begin=mg-mgr-mg-MA-Scenarioset0-0-8 /><section begin=patient-mg-mgr-mg-MA-Scenarioset0-0-8 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|S.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Jankie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910437 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-05-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset0-0-8 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset0-0-8 /><section end=mbhs-mg-mgr-mg-MA-Scenarioset0-0-8 /><section end=mg-mgr-mg-MA-Scenarioset0-0-8 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mgr-mg-MA-Scenarioset1-1-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1964-01-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-1 />
==== Scenario 1.1 - MBH_920_start_eind-BSC====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_eind_MA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_start_eind_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e24
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+5D{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_start_eind-BSC
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-1 /><section end=mg-mgr-mg-MA-Scenarioset1-1-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mgr-mg-MA-Scenarioset1-1-2a /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-2a />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1964-01-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-2a /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2a />
==== Scenario 1.2a - MBH_920_start_duur-BSC====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_duur_MA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_start_duur_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e204
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}>, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_start_duur-BSC
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2a /><section end=mg-mgr-mg-MA-Scenarioset1-1-2a />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mgr-mg-MA-Scenarioset1-1-2b /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-2b />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1964-01-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-2b /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2b />
==== Scenario 1.2b - MBH_920_start_duur2-BSC====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_start_duur2_MA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_start_duur2_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e621
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-60D{00:00:00}>, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_start_duur2-BSC
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-2b /><section end=mg-mgr-mg-MA-Scenarioset1-1-2b />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mgr-mg-MA-Scenarioset1-1-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1964-01-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-3 />
==== Scenario 1.3 - MBH_920_chronisch-BSC====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_chronisch_MA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_chronisch_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e387
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-30D{00:00:00}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_chronisch-BSC
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-3 /><section end=mg-mgr-mg-MA-Scenarioset1-1-3 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 1==
<section begin=mg-mgr-mg-MA-Scenarioset1-1-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset1-1-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van de
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Boschman
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999912100 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1964-01-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset1-1-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset1-1-4 />
==== Scenario 1.4 - MBH_920_dosis_stuks-BSC====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_dosis_stuks_MA-BSC
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_dosis_stuks_MA-BSC
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e887
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-130D{00:00:00}> t/m <T-101D{00:00:00}>, 2 maal per dag 1 inhalatie, inhalatie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag doses
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_dosis_stuks-BSC
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset1-1-4 /><section end=mg-mgr-mg-MA-Scenarioset1-1-4 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mgr-mg-MA-Scenarioset2-2-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-1 />
==== Scenario 2.1 - MBH_920_aanvullendeinstructie-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_aanvullendeinstructie_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-4M{00:00:00}> t/m <T+8M{23:59:59}>, 1 maal per dag 1 stuk, Bij het eten innemen, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-1 /><section end=mg-mgr-mg-MA-Scenarioset2-2-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mgr-mg-MA-Scenarioset2-2-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-2 />
==== Scenario 2.2 - MBH_920_toelichting-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_toelichting_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e150
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-21D{00:00:00}>, 1 maal daags 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Toelichting
|style="background-color: white;"|In overleg met specialist
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_toelichting-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-2 /><section end=mg-mgr-mg-MA-Scenarioset2-2-2 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mgr-mg-MA-Scenarioset2-2-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-3 />
==== Scenario 2.3 - MBH_920_redenvanvoorschrijven-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e279
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden van voorschrijven
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-13D{00:00:00}> t/m <T+14D{23:59:59}>, 1 maal per week 5 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per week stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-3 /><section end=mg-mgr-mg-MA-Scenarioset2-2-3 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mgr-mg-MA-Scenarioset2-2-4 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-4 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-4 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-4 />
==== Scenario 2.4 - MBH_920_aanvullendeinformatiewensen-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e408
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-4D{00:00:00}> t/m <T+5D{23:59:59}>, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende informatie
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-4 /><section end=mg-mgr-mg-MA-Scenarioset2-2-4 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 2==
<section begin=mg-mgr-mg-MA-Scenarioset2-2-5 /><section begin=patient-mg-mgr-mg-MA-Scenarioset2-2-5 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset2-2-5 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset2-2-5 />
==== Scenario 2.5 - MBH_920_Toedieningsweg-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_Toedieningsweg_MA-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_Toedieningsweg_MA-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e537
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-5D{00:00:00}> t/m <T+2D{23:59:59}>, 2 maal per dag 1 druppel, In het rechter oog, oculair
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag druppels
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende informatie
|style="background-color: white;"|3
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_Toedieningsweg-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset2-2-5 /><section end=mg-mgr-mg-MA-Scenarioset2-2-5 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-MA-Scenarioset3-3-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-1 />
==== Scenario 3.1 - MBH_920_aanvullendeinstructie-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinstructie_MA_staken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_aanvullendeinstructie_MA_staken-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e26
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|Interactie (code = '79899007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-4M{00:00:00}> t/m <T-10D{23:59:59}>, 1 maal per dag 1 stuk, Bij het eten innemen, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_aanvullendeinstructie-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-1 /><section end=mg-mgr-mg-MA-Scenarioset3-3-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-MA-Scenarioset3-3-2 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-2 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-2 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-2 />
==== Scenario 3.2 - MBH_920_toelichting-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_wijzigingmetVV-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_toelichting_MA_wijzigingmetVV-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e105
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-2D{00:00:00}> 1 maal daags 2 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_toelichting-VNK
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toelichting_MA_techstaken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_toelichting_MA_techstaken-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e151
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-21D{00:00:00}> t/m <T-3D{23:59:59}>, 1 maal daags 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_toelichting-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-2 /><section end=mg-mgr-mg-MA-Scenarioset3-3-2 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-MA-Scenarioset3-3-3 /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-3 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-3 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-3 />
==== Scenario 3.3 - MBH_920_redenvanvoorschrijven-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_wijzigingzonderVV-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e306
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden van voorschrijven
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-1D{00:00:00}> t/m <T+14D{23:59:59}>, 1 maal per week 4 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per week stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
|}
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven_MA_techstaken-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e355
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden van voorschrijven
|style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Reumatoide artritis
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-13D{00:00:00}> t/m <T-2D{23:59:59}>, 1 maal per week 5 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per week stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_redenvanvoorschrijven-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-3 /><section end=mg-mgr-mg-MA-Scenarioset3-3-3 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)==
<section begin=mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|C.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Vonker
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910401 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-02-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
==== Scenario 3.4 - MBH_920_aanvullendeinformatiewensen-VNK====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen_MA_onderbreken-VNK
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e465
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Reden wijzigen of staken
|style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+1D{00:00:00}> t/m <T+1D{23:59:59}>, 3 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Aanvullende informatie
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_aanvullendeinformatiewensen-VNK
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset3-3-4optioneel /><section end=mg-mgr-mg-MA-Scenarioset3-3-4optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 4 (Lengte/Gewicht)==
<section begin=mg-mgr-mg-MA-Scenarioset4-4-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset4-4-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|A.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Molenaars
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910449 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset4-4-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset4-4-1 />
==== Scenario 4.1 - MBH_920_Lengte_Gewicht-MLN====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_Lengte_Gewicht_MA_1-MLN
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_Lengte_Gewicht_MA_1-MLN
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e22
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-1Y{00:00:00}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_Lengte_Gewicht-MLN
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset4-4-1 /><section end=mg-mgr-mg-MA-Scenarioset4-4-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
==== Scenario 6.1 - MBH_920_variabelefrequentie-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelefrequentie_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_variabelefrequentie_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+16D{23:59:59}>, 1 à 2 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_variabelefrequentie-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-1optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
==== Scenario 6.2 - MBH_920_interval-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_interval_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_interval_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e150
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}>, exact iedere 8 uur 1 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|exact iedere 8 uur stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_interval-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-2optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
==== Scenario 6.3 - MBH_920_variabelehoeveelheid-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheid_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e269
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+28D{23:59:59}>, 3 maal per dag 1 à 2 stuks, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheid-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-3optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
==== Scenario 6.4 - MBH_920_zonderkeerdosis-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_zonderkeerdosis_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_zonderkeerdosis_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e397
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+28D{23:59:59}>, 3 maal per dag aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_zonderkeerdosis-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-4optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-4optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
==== Scenario 6.5 - MBH_920_bijzonderekeerdosis-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_bijzonderekeerdosis_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_bijzonderekeerdosis_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e517
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{18:00:00}> t/m <T+28D{23:59:59}>, 2 maal per dag 0.5 tablet
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_bijzonderekeerdosis-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-5optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-5optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
==== Scenario 6.6 - MBH_920_variabelehoeveelheid2-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheid2_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheid2_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e643
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+28D{23:59:59}>, 2 maal per dag 10 a 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag ml
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheid2-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-6optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-6optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-7 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-7 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-7 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-7 />
==== Scenario 6.7 - MBH_920_tijdstippen-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_tijdstippen_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_tijdstippen_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e775
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+14D{23:59:59}>, 3 maal daags 1 tablet, (8:00, 14:00, 20:00) oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|elke dag om 08:00:00, 14:00:00 en 20:00:00 stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_tijdstippen-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-7 /><section end=mg-mgr-mg-MA-Scenarioset6-6-7 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
==== Scenario 6.8 - MBH_920_weekdagen-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_weekdagen_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_weekdagen_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e899
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+70D{23:59:59}>, op maandag, woensdag en vrijdag, voor de nacht aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Aanvullende instructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|op maandag, woensdag en vrijdag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_weekdagen-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-8optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-8optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-9 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-9 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-9 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-9 />
==== Scenario 6.9 - MBH_920_dagdeel-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_dagdeel_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_dagdeel_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1018
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}>, 1 maal per dag 1 stuk ’s avonds, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|stuks 's avonds
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_dagdeel-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-9 /><section end=mg-mgr-mg-MA-Scenarioset6-6-9 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
==== Scenario 6.10 - MBH_920_cyclischschema-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_cyclischschema_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_cyclischschema_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1136
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="5"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D>, cyclus van 28 dagen: gedurende 21 dagen 1 x per dag 1 tablet, dan 7 dagen niet, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|gedurende 21 dagen maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Herhaalperiode cyclisch schema
|style="background-color: white;"|28
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_cyclischschema-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-10optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-10optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
==== Scenario 6.11 - MBH_920_afbouwschema-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_afbouwschema_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_afbouwschema_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1266
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+41D{23:59:59}>, eerst gedurende 2 weken 3gram per dag, dan gedurende 3 weken 2gram per dag, dan gedurende 6 dagen 1gram per dag, dun aanbrengen, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 1
|style="background-color: white;"|eerst gedurende 2 weken maal per dag gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 2
|style="background-color: white;"|dan gedurende 3 weken maal per dag gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie 3
|style="background-color: white;"|dan gedurende 6 dagen maal per dag gram
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_afbouwschema-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-11optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-11optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
==== Scenario 6.12 - MBH_920_variabelehoeveelheidenmaximum-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1448
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+21D{23:59:59}>, 1 a 2 stuks bij hoest, maximaal 6 stuks per dag, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|stuks , maximaal 6 stuks per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_variabelehoeveelheidenmaximum-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-12optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-12optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
==== Scenario 6.13 - MBH_920_toedieningssnelheid-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toedieningssnelheid_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_toedieningssnelheid_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1580
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+8D{23:59:59}>, 0.2 a 0.5 ml per uur parenteraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|toedieningssnelheid: ml per uur
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_toedieningssnelheid-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-13optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-13optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
==== Scenario 6.14 - MBH_920_toedieningsduur-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_toedieningsduur_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_toedieningsduur_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1699
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}>, eenmaal daags 1 pleister aanbrengen gedurende 16 uur, transdermaal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_toedieningsduur-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-14optioneel /><section end=mg-mgr-mg-MA-Scenarioset6-6-14optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 6 (Doseerschemas)==
<section begin=mg-mgr-mg-MA-Scenarioset6-6-15 /><section begin=patient-mg-mgr-mg-MA-Scenarioset6-6-15 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|N.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Maasz
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910747 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-10
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|3
|}<section end=patient-mg-mgr-mg-MA-Scenarioset6-6-15 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset6-6-15 />
==== Scenario 6.15 - MBH_920_zonodig-MSZ====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_zonodig_MA-MSZ
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_zonodig_MA-MSZ
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e1826
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+27D{23:59:59}>, 1 maal per dag 1 stuk zo nodig, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_zonodig-MSZ
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset6-6-15 /><section end=mg-mgr-mg-MA-Scenarioset6-6-15 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1970-05-05
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
==== Scenario 7.1 - MBH_920_magistraalalleingredienten-TST====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraalalleingredienten_MA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_magistraalalleingredienten_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e23
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+31D{23:59:59}> zo nodig, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_magistraalalleingredienten-TST
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-1optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1970-05-05
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
==== Scenario 7.2 - MBH_920_magistraalactieveingredient-TST====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraalactieveingredient_MA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_magistraalactieveingredient_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e215
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+1D{00:00:00}> t/m <T+70D{23:59:59}>, 1x daags, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_magistraalactieveingredient-TST
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-2optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 7 (Magistraal)==
<section begin=mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="6"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|R.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX-TEST-E
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999990196 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1970-05-05
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
==== Scenario 7.3 - MBH_920_magistraal90miljoennr-TST====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_magistraal90miljoennr_MA-TST
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_magistraal90miljoennr_MA-TST
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e375
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D{00:00:00}> t/m <T+30D{23:59:59}>, 1x per dag, cutaan
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_magistraal90miljoennr-TST
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset7-7-3optioneel /><section end=mg-mgr-mg-MA-Scenarioset7-7-3optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8 (andermans MA)==
<section begin=mg-mgr-mg-MA-Scenarioset8-8-1 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8-8-1 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Zutphen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910498 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8-8-1 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8-8-1 />
==== Scenario 8.1 - MBH_920_VVandermansMA-ZTP====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e24
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-14D{00:00:00}> t/m <T+6D{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Kopie indicator
|style="background-color: white;"|true
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_VVandermansMA-ZTP
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8-8-1 /><section end=mg-mgr-mg-MA-Scenarioset8-8-1 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Zutphen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910498 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
==== Scenario 8i.01 - MBH_920_VVandermansMA-ZTP====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_VVandermansMA_MA-ZTP
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_VVandermansMA_MA-ZTP
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e24
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-14D{00:00:00}> t/m <T+6D{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_VVandermansMA-ZTP
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-01 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-01 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Zutphen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910498 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
==== Scenario 8i.02 - MBH_920_stakenandermansMA-ZTP====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_stakenandermansMA_MA1-ZTP
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_stakenandermansMA_MA1-ZTP
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e248
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-5D{00:00:00}> t/m <T+15D{23:59:59}>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_stakenandermansMA-ZTP
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-02 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-02 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Zutphen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910498 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
==== Scenario 8i.03 - MBH_920_onderbrekenandermansMA-ZTP====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_onderbrekenandermansMA_MA1-ZTP
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_onderbrekenandermansMA_MA1-ZTP
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e451
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-60D{00:00:00}> t/m <T+30D>{23:59:59}, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_onderbrekenandermansMA-ZTP
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-03 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-03 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 8.0 (andermans MA)==
<section begin=mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section begin=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|H.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Zutphen
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999910498 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-06-08
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
==== Scenario 8i.04 - MBH_920_wijzigenandermansMA-ZTP====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_wijzigenandermansMA_MA1-ZTP
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_wijzigenandermansMA_MA1-ZTP
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e697
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-7D{00:00:00}> t/m <T+13D{23:59:59}>, 1 maal per dag 2 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_wijzigenandermansMA-ZTP
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset8.0-8i-04 /><section end=mg-mgr-mg-MA-Scenarioset8.0-8i-04 />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 10 (HPKZI)==
<section begin=mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|B.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Kester
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999911557 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-02
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
==== Scenario 10.1 - MBH_920_HPKvoorschrijven-KST====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_HPKvoorschrijven_MA-KST
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_HPKvoorschrijven_MA-KST
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e24
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T-170D> t/m <T-21D>, 1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_HPKvoorschrijven-KST
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset10-10-1optioneel /><section end=mg-mgr-mg-MA-Scenarioset10-10-1optioneel />
== MP KWALIFICATIE Medicatiegegevens MA Scenarioset 10 (HPKZI)==
<section begin=mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section begin=patient-mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="5" | Patiënt
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="4" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="5"|Naamgegevens
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="7"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Initialen
|style="background-color: white;"|B.
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Naamgebruik
|style="background-color: white;"|1
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Geslachtsnaam
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="3"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Voorvoegsels
|style="background-color: white;"|van
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Achternaam
|style="background-color: white;"|XXX_Kester
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Identificatienummer
|style="background-color: white;"|999911557 [BSN]
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geboortedatum
|style="background-color: white;"|1954-08-02
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="4"|Geslacht
|style="background-color: white;"|2
|}<section end=patient-mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section begin=mbhs-mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
==== Scenario 10.2 - MBH_920_ZINRvoorschrijven-KST====
{| class="wikitable" width="85%"
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;"  colspan="4" | Medicatieafspraak MBH_920_ZINRvoorschrijven_MA-KST
|-style="background-color: #1F497D;; color: white; text-align:left;"
|colspan="3" width="25%"| Gegevenselement
|| Waarde
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|Identificatie
|style="background-color: white;"|MBH_920_ZINRvoorschrijven_MA-KST
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Voorschrijver
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="2"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Zorgverlener
|style="background-color: white;"|d4e152
|-style="vertical-align:top; background-color: #E3E3E3;;" 
|colspan="4"|Gebruiksinstructie
|-style="vertical-align:top; background-color: #E3E3E3;;"
|rowspan="4"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Omschrijving
|style="background-color: white;"|Vanaf <T+0D> t/m <T+150D>,1 maal per dag 1 stuk, oraal
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Toedieningsweg
|style="background-color: white;"|
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="2"|Doseerinstructie
|style="background-color: white;"|maal per dag stuks
|-style="vertical-align:top; background-color: #E3E3E3;;"
|colspan="3"|MBH identificatie
|style="background-color: white;"|MBH_920_ZINRvoorschrijven-KST
|}<section end=mbhs-mg-mgr-mg-MA-Scenarioset10-10-2optioneel /><section end=mg-mgr-mg-MA-Scenarioset10-10-2optioneel />
[[Categorie:Kwalificatie]]

Huidige versie van 30 sep 2022 om 13:40

Tabel 1. Overzicht situaties specifieke en generieke MBH-id voor EVS en AIS
Situatie EVS AIS ETDR
Migreren van actuele en recent gestopte medicatie Specifieke MBH-id Generieke MBH-id Generieke MBH-id
Migreren van historische medicatie Generieke MBH-id Generieke MBH-id Generieke MBH-id
Starten van nieuwe MBH Specieke MBH-id Generieke MBH-id[1] Generieke MBH-id
  1. ↑ AIS initieert in principe géén specifieke MBH-id. Alleen wanneer er geen PRK is, maakt het AIS een specifieke MBH-id aan (zie paragraaf Bijzondere situaties).
Overgenomen van "https://informatiestandaarden.test-nictiz.nl/index.php?title=mp:Vdraft_Sandbox&oldid=137150"